Helicobacter Pylori Infections Clinical Trial
Official title:
Distribution of Helicobacter Pylori in Remnant Stomach After Subtotal Gastrectomy
The purpose of this study is to know the distribution of Helicobacter pylori in stomach before subtotal gastrectomy and after subtotal gastrectomy.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | March 21, 2020 |
Est. primary completion date | March 21, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years to 75 Years |
Eligibility |
Inclusion Criteria: 1. Patients who are indicated to subtotal gastrectomy due to gastric neoplasm 2. Aged between 19 to 75 years 3. Informed consent Exclusion Criteria: 1. Previous history of Helicobacter pylori eradication 2. Previous history of proton pump inhibitor use within 6 months |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Asan Medical Center | Seoul | Songpa-gu |
Lead Sponsor | Collaborator |
---|---|
Asan Medical Center |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Distribution of Helicobacter Pylori After Gastrectomy | Analysis the change of Helicobacter pylori according to the subtotal gastrectomy | Change in the distribution of Helicobacter Pylori at 2 years | |
Secondary | Change of atrophy after gastrectomy | Analysis the change of atrophic status according to the subtotal gastrectomy | Change in the atrophic status at 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02123771 -
Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections
|
Phase 1 | |
Recruiting |
NCT02047994 -
Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
|
Phase 4 |